Desarrollo y Teratología del Sistema Nervioso Central y Órganos de los Sentidos. Neurogénesis. Neurorregeneración.
![Foto de Desarrollo y Teratología del Sistema Nervioso Central y Órganos de los Sentidos. Neurogénesis. Neurorregeneración.](/img/uploaded/4C1320636337A52F5891CAA0FC259BD6.png)
![Foto de Universitat Autònoma de Barcelona](/img/noimage_org.png)
Universitat Autònoma de Barcelona
Barcelona, EspañaUniversitat Autònoma de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (58)
2024
-
Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct: a secondary analysis of the SELECT2 randomized trial
Journal of NeuroInterventional Surgery, pp. 1-8
2023
-
Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy
Frontiers in Aging Neuroscience, Vol. 15
-
Intracranial atherosclerotic plaque enhancement and long-term risk of future strokes: A prospective, longitudinal study
Journal of Neuroimaging, Vol. 33, Núm. 2, pp. 289-301
2022
-
A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype
Frontiers in Cardiovascular Medicine, Vol. 9
-
Blood-Based Biomarkers to Search for Atrial Fibrillation in High-Risk Asymptomatic Individuals and Cryptogenic Stroke Patients
Frontiers in Cardiovascular Medicine, Vol. 9
-
International controlled study of revascularization and outcomes following COVID-positive mechanical thrombectomy
European Journal of Neurology, Vol. 29, Núm. 11, pp. 3273-3287
-
Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke
Brain, Vol. 145, Núm. 7, pp. 2394-2406
-
Proteins and pathways in atrial fibrillation and atrial cardiomyopathy underlying cryptogenic stroke
IJC Heart and Vasculature, Vol. 39
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke
European Journal of Neurology, Vol. 28, Núm. 2, pp. 540-547
-
Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry
International Journal of Stroke, Vol. 16, Núm. 4, pp. 437-447
-
Circulating AQP4 levels in patients with cerebral amyloid angiopathy-associated intracerebral hemorrhage
Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-15
-
Comparison of plasma lipoprotein composition and function in cerebral amyloid angiopathy and alzheimer’s disease
Biomedicines, Vol. 9, Núm. 1, pp. 1-14
-
Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome
Stroke, Vol. 52, Núm. 1, pp. 132-141
-
Predicting Atrial Fibrillation with High Risk of Embolization with Atrial Strain and NT-proBNP
Translational Stroke Research, Vol. 12, Núm. 5, pp. 735-741
-
Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis
Journal of Clinical Medicine, Vol. 10, Núm. 14
-
SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group
Stroke, Vol. 52, Núm. 5, pp. E117-E130
-
Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma
Brain, Vol. 144, Núm. 8, pp. 2416-2426
-
Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry
BMC Neurology, Vol. 21, Núm. 1